Skip to search formSkip to main contentSkip to account menu

Bonefos

National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

ClodronateClodronate DisodiumClodronic Acid

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Treatment for experimental autoimmune neuritis with clodronate (Bonefos)
Experimental autoimmune neuritis (EAN) serves as an animal model for human Gullain–Barre syndrome (GBS), an autoimmune disease… 
Highly Cited
2008
Highly Cited
2008
Vertebral Fracture Assessment (VFA) With a Densitometer Predicts Future Fractures in Elderly Women Unselected for Osteoporosis
Low radiation dose imaging of the lateral spine acquired with a bone densitometer for vertebral fracture assessment (VFA) has… 
2008
2008
Comparison of the Effects of Ibandronate and Bonefos on Non-small Cell Lung Cancer with Bone Metastases
Objective: To evaluate the clinical efficacy and safety of Ibandronate and Bonefos for non-small cell lung cancer (NSCLC) with… 
Highly Cited
2006
Highly Cited
2006
Correction: Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]
It has been brought to our attention that there was a typographical error in our recent article [1] published in March 2006. 
Highly Cited
2004
Highly Cited
2004
Clodronate Reduces Vertebral Fracture Risk in Women With Postmenopausal or Secondary Osteoporosis: Results of a Double‐Blind, Placebo‐Controlled 3‐Year Study
The efficacy of oral clodronate 800 mg daily to reduce vertebral fractures was studied in 593 women with postmenopausal or… 
Review
2004
Review
2004
Toward new horizons: the future of bisphosphonate therapy.
Bisphosphonate therapy has become a standard of care for patients with malignant bone disease. In addition, preclinical and… 
2004
2004
Oral clodronate for adjuvant treatment of operable breast cancer: Results of a randomized, double-blind, placebo-controlled multicenter trial.
528 Background: The bisphosphonate clodronate (Bonefos) may reduce the incidence of bone metastases by inhibiting tumor-induced… 
Highly Cited
2003
Highly Cited
2003
Extended Safety Profile of Oral Clodronate After Long-Term Use in Primary Breast Cancer Patients
AbstractIntroduction: Long-term safety and tolerance is paramount when treating women who are otherwise healthy after the primary… 
2002
2002
[⁸⁹SrCl₂ and/or Bonefos in the treatment of bone metastasis from pulmonary carcinoma].
BACKGROUND To evaluate the effect of ⁸⁹SrCl₂ and/or Bonefos in the treatment of bone metastasis from pulmonary carcinoma… 
2000
2000
Timing of food intake has a marked effect on the bioavailability of clodronate.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)